COVID-19 in pregnancy not linked with stillbirth or baby death
25 February 2021
COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study.
25 February 2021
COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death, according to a new study.
23 February 2021
The Pfizer-BioNTech COVID-19 vaccine provides high levels of protection, analysis of healthcare workers who had the jab found.
23 February 2021
Join healthcare specialists working in COVID-19 vaccine research in the South of England to learn what we know about COVID-19 vaccines so far and the role research can continue to play.
15 February 2021
A study is to launch into whether the University of Oxford’s COVID-19 vaccine can offer protection to children and young adults.
11 February 2021
Shamin Durrani is a Research Champion, where members of the public volunteer to spread the word about health and care research. She joined the role to be an ambassador for research in ethnic minority communities.
11 February 2021
Tocilizumab reduces the risk of death for hospitalised patients with severe COVID-19, NIHR-backed research has found.
04 February 2021
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines has opened in Oxford.
04 February 2021
Research nurse Annie Rose is to begin a doctorate in the healthcare experience of transgender and gender-diverse people.
29 January 2021
A COVID-19 vaccine is 89.3% effective at preventing the virus, including new variants, interim results show.
28 January 2021
Angela Minassian is the principal investigator on a trial of a COVID-19 vaccine developed by US company Novavax, which has recruited 463 participants at the NIHR cognitive health Clinical Research Facility, based at Oxford’s Warneford Hospital
26 January 2021
Two commonly used antibiotics do not reduce recovery time for COVID-19 patients in the community, a study has found.
26 January 2021
People are invited to an event about research into COVID-19 treatments featuring a doctor and a patient who were involved in the study.
18 January 2021
A COVID-19 treatment study has found using convalescent plasma does not reduce deaths.
18 January 2021
People who have had COVID-19 are likely to be protected against reinfection for several months but could still carry the virus, NIHR-supported research found.
15 January 2021
Researchers have developed a new risk stratification tool that can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19.
08 January 2021
Intensive care patients with COVID-19 are to get a drug that can improve survival and reduce hospital stays, following results from an NIHR-supported study.
05 January 2021
More than 9,400 participants took part in nationally-prioritised research studies into COVID-19 in Thames Valley and South Midlands this year.
30 December 2020
The Government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use.
23 December 2020
A website designed to be a ‘one stop shop’ on working at the LCRN has been updated with new features and content.
23 December 2020
A common treatment for chronic subdural haematoma could lead to a worse outcome than receiving no medication, suggests new research funded by the NIHR.
15 December 2020
Louise Mew, a surgical research nurse at Milton Keynes University Hospital (MKUH), on how her role has changed during the COVID-19 pandemic.
15 December 2020
The NIHR-supported RECOVERY trial has found no clinical benefit from the antibiotic azithromycin for hospitalised patients with severe COVID-19.
15 December 2020
Researchers supported by NIHR have identified potential treatments for COVID-19 after the discovery of five genes associated with the most severe form of the disease.
11 December 2020
Four members of staff have joined the Research and Innovation Team at Buckinghamshire Healthcare NHS Trust.
08 December 2020
A COVID-19 vaccine developed by the University of Oxford is up to 90% effective, a peer-reviewed paper in The Lancet has confirmed.